R Möricke

Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial

David L. Kendler, Fernando Marín, Cristiano A. F. Zerbini et al. · The Lancet · 2017 · 581 citations · Full text

Medicine, Endocrinology, Gynecology +15

Secukinumab in Active Rheumatoid Arthritis: A Phase III Randomized, Double‐Blind, Active Comparator– and Placebo‐Controlled Study

Francisco J. Blanco, R Möricke, Eva Dokoupilová et al. · Arthritis & Rheumatology · 2017 · 182 citations

Medicine, Immunology, Pharmacotherapy +17

Comparative effects of teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18-month results of the EuroGIOPs trial

Claus‐C. Glüer, Fernando Marín, J. D. Ringe et al. · Journal of Bone and Mineral Research · 2013 · 173 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

Comparative Effects of Teriparatide and Strontium Ranelate on Bone Biopsies and Biochemical Markers of Bone Turnover in Postmenopausal Women With Osteoporosis

Robert R. Recker, Fernando Marín, Sophia Ish‐Shalom et al. · Journal of Bone and Mineral Research · 2009 · 117 citations · Full text

Medicine, Orthopedic Surgery, Bone Metabolism +16

Correlations between biochemical markers of bone turnover and bone density responses in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate

Alan Burshell, R Möricke, Ricardo Correa‐Rotter et al. · Bone · 2010 · 46 citations

Medicine, Endocrinology, Orthopedic Surgery +17